Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 96

1.

The MIG Chemokine in Inflammatory Myopathies.

Paparo SR.

Clin Ter. 2019 Jan-Feb;170(1):e55-e60. doi: 10.7417/CT.2019.2108. Review.

2.

Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays.

Damoiseaux J, Vulsteke JB, Tseng CW, Platteel ACM, Piette Y, Shovman O, Bonroy C, Hamann D, De Langhe E, Musset L, Chen YH, Shoenfeld Y, Allenbach Y, Bossuyt X.

Autoimmun Rev. 2019 Mar;18(3):293-305. doi: 10.1016/j.autrev.2018.10.004. Epub 2019 Jan 11. Review.

PMID:
30639643
3.

Coronary artery dilation associated with anti-synthetase syndrome in an adolescent.

Asi K, Gourishankar A, Kamdar A.

Pediatr Rheumatol Online J. 2019 Jan 10;17(1):3. doi: 10.1186/s12969-019-0304-y.

4.

hsa-miR-7 Is a Potential Biomarker for Idiopathic Inflammatory Myopathies with Interstitial Lung Disease in Humans.

Yu L, Li J, Chen Y, Jiang J, Fang Q, Jiang J, Wang D, Liu M.

Ann Clin Lab Sci. 2018 Nov;48(6):764-769.

PMID:
30610047
5.

Treatment of idiopathic inflammatory myositis associated interstitial lung disease: A systematic review and meta-analysis.

Barba T, Fort R, Cottin V, Provencher S, Durieu I, Jardel S, Hot A, Reynaud Q, Lega JC.

Autoimmun Rev. 2019 Feb;18(2):113-122. doi: 10.1016/j.autrev.2018.07.013. Epub 2018 Dec 17.

PMID:
30572131
6.

Dermatomyositis as a paraneoplastic phenomenon in oesophageal cancer.

Laidler NK.

BMJ Case Rep. 2018 Dec 7;11(1). pii: e227387. doi: 10.1136/bcr-2018-227387.

PMID:
30567206
7.

One year in review 2018: idiopathic inflammatory myopathies.

Marasco E, Cioffi E, Cometi L, Valentini V, Zanframundo G, Neri R, Cavagna L, Barsotti S.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6):937-947. Epub 2018 Dec 6. Review.

8.

Exploring Road of Classification Criteria for Idiopathic Inflammatory Myopathy.

Li YH, Wang GC, Li ZG.

Chin Med J (Engl). 2018 Dec 5;131(23):2773-2775. doi: 10.4103/0366-6999.246082. No abstract available.

9.

Idiopathic Inflammatory Myopathy and Antisynthetase Syndrome: Early Diagnosis by 99mTc-HDP Bone Scintigraphy.

Fernández-Rodríguez P, Martín-Marcuartu JJ, Jiménez-Hoyuela JM.

Clin Nucl Med. 2018 Dec;43(12):939-940. doi: 10.1097/RLU.0000000000002312.

PMID:
30325823
10.

The role of imaging in evaluating patients with idiopathic inflammatory myopathies.

Kubínová K, Dejthevaporn R, Mann H, Machado PM, Vencovský J.

Clin Exp Rheumatol. 2018 Sep-Oct;36 Suppl 114(5):74-81. Epub 2018 Oct 1. Review.

11.

Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.

Jiao Y, Cai S, Lin J, Zhu W, Xi J, Li J, Yue D, Zhang T, Qiao K, Wang Y, Zhao C, Lu J.

J Clin Neurosci. 2018 Nov;57:13-19. doi: 10.1016/j.jocn.2018.08.010. Epub 2018 Sep 8.

PMID:
30205933
12.

T-cell transcriptomics from peripheral blood highlights differences between polymyositis and dermatomyositis patients.

Houtman M, Ekholm L, Hesselberg E, Chemin K, Malmström V, Reed AM, Lundberg IE, Padyukov L.

Arthritis Res Ther. 2018 Aug 29;20(1):188. doi: 10.1186/s13075-018-1688-7.

13.

Long-term follow-up of 76 Iranian patients with idiopathic inflammatory myopathies.

Hajialilo M, Ghorbanihaghjo A, Khabbazi A, Kolahi S, Jafari Nakhjavani MR, Ebrahimi AA, Zareh H, Malek Mahdavi A.

Int J Rheum Dis. 2018 Aug;21(8):1627-1633. doi: 10.1111/1756-185X.13352.

PMID:
30146744
14.

Targeted capture sequencing identifies novel genetic variations in Chinese patients with idiopathic inflammatory myopathies.

Peng QL, Lin JM, Zhang YB, Zhang XZ, Wang PP, Wu TT, Yu J, Dong XQ, Gu ML, Wang GC.

Int J Rheum Dis. 2018 Aug;21(8):1619-1626. doi: 10.1111/1756-185X.13350.

PMID:
30146738
15.

Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.

Zampeli E, Venetsanopoulou A, Argyropoulou OD, Mavragani CP, Tektonidou MG, Vlachoyiannopoulos PG, Tzioufas AG, Skopouli FN, Moutsopoulos HM.

Clin Rheumatol. 2019 Jan;38(1):125-132. doi: 10.1007/s10067-018-4267-z. Epub 2018 Aug 25.

PMID:
30145635
16.

Inclusion Body Myositis: Update on Pathogenesis and Treatment.

Naddaf E, Barohn RJ, Dimachkie MM.

Neurotherapeutics. 2018 Oct;15(4):995-1005. doi: 10.1007/s13311-018-0658-8. Review.

PMID:
30136253
17.

Dermatomyositis as an extrahepatic manifestation of hepatitis B virus-related hepatocellular carcinoma: A case report and literature review.

Han J, Wang S, Kwong TNY, Liu J.

Medicine (Baltimore). 2018 Aug;97(33):e11586. doi: 10.1097/MD.0000000000011586. Review.

18.

Dermatomyositis Developing Post Neoadjuvant Chemotherapy and Lumpectomy.

Wong DE, Williams E, Warrier S.

R I Med J (2013). 2018 Aug 1;101(6):34-36.

PMID:
30068052
19.

Prevalence and reactivity of anti-melanoma differentiation-associated gene 5 (anti-MDA-5) autoantibody in Brazilian patients with dermatomyositis.

Borges IBP, Silva MG, Shinjo SK.

An Bras Dermatol. 2018 Jul-Aug;93(4):517-523. doi: 10.1590/abd1806-4841.20186803.

20.

Juvenile Idiopathic Inflammatory Myopathies.

Huber AM.

Pediatr Clin North Am. 2018 Aug;65(4):739-756. doi: 10.1016/j.pcl.2018.04.006. Review.

PMID:
30031496

Supplemental Content

Loading ...
Support Center